ALBERT BOURLA - 30 Sep 2021 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Issuer symbol
PFE
Transactions as of
30 Sep 2021
Net transactions value
+$516
Form type
4
Filing time
01 Oct 2021, 15:42:49 UTC
Previous filing
16 Sep 2021
Next filing
13 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Award $516 +12 +0.01% $43.01 89,302 30 Sep 2021 Common Stock 12 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.